Stocks To Buy Now

Blog


21st BioPharma Drug Discovery Nexus To Invite Leaders from the Global Fraternity

The 21st BioPharma Drug Discovery Nexus will be held on October 22-23, 2024, at the Holiday Inn Piscataway – Somerset, in New Jersey. New Jersey was selected as the venue for the event, as this northeastern state has been at the helm of biotech and pharma innovations and research. Experts from the region and all across the globe will grace the event and discuss challenges and opportunities in the field of drug discovery.

The event is organized by BioPharma Nexus, a trusted player in fostering connections between pharmaceutical and biotech companies, along with key service providers. Their goal is to provide the best healthcare to patients all over the globe. Service providers and businesses in biotech, pharma and healthcare, can identify and connect with partners to foster scientific and healthcare collaborations.

The event agenda:

  • Automation & Computational Drug Design
  • Antibody Therapeutics & Protein Engineering
  • Novel Targets: Exploring Modalities in Drug Discovery
  • Advancement in Cell & Gene Therapy

The 21st BioPharma Dug Discovery Nexus engages the attendees in interactive discussions, presentations and keynote speaker sessions. The speakers presiding over the keynote sessions are eminent representatives, with important insight and experience in their industry. These stalwarts from the biopharma industry will share critical information and discuss the latest trends in the industry.

New and established entities in the drug discovery spectrum can expand their connections in the pharma space. It is a phenomenal learning experience as they can get answers from top industry experts. The networking breaks offer attendees a comfortable window to connect directly with industry leaders.

To learn more, please visit https://ibn.fm/TKTOR.

From Our Blog

Brera Holdings PLC (NASDAQ: BREA) Expands Commitment to Women’s Football and Multi-Club Ownership (‘MCO’) Model

March 21, 2025

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, has reiterated its commitment to advancing women’s soccer. In a joint report co-authored with leading global law firm Clifford Chance LLP, Brera outlines the benefits of MCO models […]

Rotate your device 90° to view site.